Core Viewpoint - Jiangsu Gaokai Precision Fluid Technology Co., Ltd. (referred to as "Gaokai Technology") has officially submitted its application for listing on the Sci-Tech Innovation Board, aiming to raise approximately 1.5 billion yuan for high-end semiconductor equipment component R&D, R&D center construction, and working capital supplementation [1][4]. Company Overview - Established in 2013, Gaokai Technology focuses on the R&D, production, and sales of key control components and related equipment in the precision fluid control field [3]. - The company has developed three core business segments: flow control series, dispensing packaging series, and precision coating series, with applications in semiconductor, consumer electronics, automotive electronics, and new energy sectors [3]. Market Position and Achievements - Gaokai Technology is one of the few domestic suppliers capable of mass production and application of key fluid control components in advanced semiconductor processes, including products used in 7nm and below logic chip manufacturing [3]. - The company's products have been validated by well-known domestic manufacturers, achieving stable mass production supply [3]. - In the semiconductor equipment fluid control sector, Gaokai's self-developed products are widely used in wafer manufacturing processes such as etching, thin film deposition, and cleaning, serving several leading domestic semiconductor equipment companies [3]. Recent Developments - This is Gaokai Technology's second attempt to list on the Sci-Tech Innovation Board, having previously been accepted in June 2021 but terminating the review in December of the same year [4]. - The renewed application reflects the company's commitment to the precision fluid control field and significant progress in core technology breakthroughs and market expansion [4]. Industry Outlook - Analysts note that the demand for precision fluid control is continuously growing due to the accelerated localization of semiconductor equipment and the rapid development of the new energy industry [4]. - Successful listing on the Sci-Tech Innovation Board would provide Gaokai Technology with more substantial financial support, potentially solidifying its leading position in the key components of semiconductor equipment and promoting the realization of more core technologies being self-controlled [4].

Group 1: Company Overview - Xian New Tong Pharmaceutical Research Co., Ltd. focuses on drug development for major liver diseases, including hepatitis B and liver cancer, with 8 core products in its pipeline [1] - Renben Co., Ltd. is the largest comprehensive bearing manufacturing group in China, with over 50,000 product specifications and a presence in over 70 countries [2] - Wolai Intelligent Technology Co., Ltd. specializes in smart manufacturing solutions for emerging industries, particularly in the automotive and semiconductor sectors [2] - Gaokai Technology is engaged in precision fluid control, with products used in semiconductor and consumer electronics industries [3] - Deep Blue Ocean Technology Co., Ltd. develops underwater robotics and solutions for various marine applications, holding 15 core technologies in the field [3] - Tongxin Medical Technology Co., Ltd. is an innovative medical device company focused on advanced heart failure treatments, with its first product approved in China and others in clinical trials [4] Group 2: Product Development and Market Position - New Tong Pharmaceutical has developed a first-class innovative drug, with one product already on the market and others in various clinical trial stages [1] - Renben has maintained the top position in domestic bearing production and sales for 12 consecutive years, nearing the capabilities of the top eight global competitors [2] - Wolai is recognized as a national key "little giant" enterprise, providing comprehensive smart manufacturing solutions [2] - Gaokai's product range includes flow control and precision dispensing systems, catering to the needs of intelligent manufacturing [3] - Deep Blue has established itself as a pioneer in the underwater robotics sector, with a complete product line and significant R&D investment [3] - Tongxin's CH-VAD system is the first fully magnetic levitation left ventricular assist device approved in China, with further innovations in the pipeline [4]